We provide investors in healthcare, social care and pharmaceuticals with regulatory and reimbursement due diligence services through a detailed national, multinational and local policy analysis conducted by a multinational team with deep knowledge of regulatory and reimbursement activity. We understand the importance of being able to see the political, economic and cultural nuances that impact market conditions across Europe and provide the granular insights that matter to our clients.

Our Pan-European Transaction Advisory team is comprised of multi-lingual individuals with experience in the European Parliament as well as the major countries in Europe.